Boston Biomedical Associates

Our mission at Thermo Fisher is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity.

Founded in 1965, Abt Associates is one of the largest, employee-owned, government and business research and consulting companies in the United States. The company offers scientific research, consulting and technical assistance solutions in the areas of international development and clinical trials and registries. It serves several government agencies, international organizations, foundations, nonprofit associations and institutions. Abt Associates serves the telecommunications, educational, environment and financial service sectors. The company works with a team of more than 1,250 staff members. It operates over five 7 offices in the United States and nearly 40 project sites in approximately 35 countries worldwide. With annual revenues of more than $225 million, Abt Associates has survey data collection, management, analysis, and research and evaluation capabilities.

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.